BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lei YC, Hao YH, Zhang ZM, Tian YJ, Wang BJ, Yang Y, Zhao XP, Lu MJ, Gong FL, Yang DL. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivoWorld J Gastroenterol 2006; 12(28): 4492-4497 [PMID: 16874860 DOI: 10.3748/wjg.v12.i28.4492]
URL: https://www.wjgnet.com/1007-9327/full/v12/i28/4492.htm
Number Citing Articles
1
Min Liu, Youhua Hao, Honghui Ding, Dongliang Yang, Mengji Lu. Interleukin-10 is expressed in HepG2.2.15 cells and regulated by STAT1 pathwayJournal of Huazhong University of Science and Technology [Medical Sciences] 2011; 31(5): 625 doi: 10.1007/s11596-011-0572-3
2
BO QIN, TINGTING HE, ZHIJUN CHEN, WENYING XU, GUOSHAO PAN, CHUNYU TU. A novel method for the analysis of drug-resistant phenotypes of hepatitis B virusInternational Journal of Molecular Medicine 2013; 31(4): 975 doi: 10.3892/ijmm.2013.1277
3
Xingyue Ji, Zhuorong Li. Medicinal chemistry strategies toward host targeting antiviral agentsMedicinal Research Reviews 2020; 40(5): 1519 doi: 10.1002/med.21664
4
Mihaela Olivia Dobrica, Christy Susan Varghese, James Michael Harris, Jack Ferguson, Andrea Magri, Roland Arnold, Csilla Várnai, Joanna L. Parish, Jane A. McKeating. CTCF regulates hepatitis B virus cccDNA chromatin topology Journal of General Virology 2024; 105(1) doi: 10.1099/jgv.0.001939
5
Yuan Zhang, Xiaorong Chen, Yajuan Cao, Zongguo Yang. Roles of APOBEC3 in hepatitis B virus (HBV) infection and hepatocarcinogenesisBioengineered 2021; 12(1): 2074 doi: 10.1080/21655979.2021.1931640
6
Jingjiao Song, Yun Zhou, Sheng Li, Baoju Wang, Xin Zheng, Jun Wu, Kathrin Gibbert, Ulf Dittmer, Mengji Lu, Dongliang Yang, Wang-Shick Ryu. Susceptibility of Different Hepatitis B Virus Isolates to Interferon-Alpha in a Mouse Model Based on Hydrodynamic InjectionPLoS ONE 2014; 9(3): e90977 doi: 10.1371/journal.pone.0090977
7
Hadi Peeridogaheh, Zahra Meshkat, Shahram Habibzadeh, Mohsen Arzanlou, Jafar Mohammad Shahi, Sina Rostami, Sina Gerayli, Roghayeh Teimourpour. Current concepts on immunopathogenesis of hepatitis B virus infectionVirus Research 2018; 245: 29 doi: 10.1016/j.virusres.2017.12.007
8
Jianbo Xia, Weipeng Wang, Lei Li, Zhi Liu, Min Liu, Dongliang Yang. Inhibition of HBV replication by VPS4B and its dominant negative mutant VPS4B-K180Q in vivoJournal of Huazhong University of Science and Technology [Medical Sciences] 2012; 32(3): 311 doi: 10.1007/s11596-012-0054-2
9
Shiva Sadeghpour, Saeideh Khodaee, Mostafa Rahnama, Hamzeh Rahimi, Diako Ebrahimi. Human APOBEC3 Variations and Viral InfectionViruses 2021; 13(7): 1366 doi: 10.3390/v13071366
10
Huan Yan, Bo Peng, Wenhui He, Guocai Zhong, Yonghe Qi, Bijie Ren, Zhenchao Gao, Zhiyi Jing, Mei Song, Guangwei Xu, Jianhua Sui, Wenhui Li. Molecular Determinants of Hepatitis B and D Virus Entry Restriction in Mouse Sodium Taurocholate Cotransporting PolypeptideJournal of Virology 2013; 87(14): 7977 doi: 10.1128/JVI.03540-12
11
Fumiaki Ito, Yang Fu, Shen-Chi A. Kao, Hanjing Yang, Xiaojiang S. Chen. Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC ProteinsJournal of Molecular Biology 2017; 429(12): 1787 doi: 10.1016/j.jmb.2017.04.021
12
Ritu Goila-Gaur, Mohammad A Khan, Eri Miyagi, Sandra Kao, Klaus Strebel. Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activityRetrovirology 2007; 4(1) doi: 10.1186/1742-4690-4-61
13
Weiwei Wang, Hongquan Peng, Jiafu Li, Xiping Zhao, Fei Zhao, Kanghong Hu. Controllable inhibition of hepatitis B virus replication by a DR1-targeting short hairpin RNA (shRNA) expressed from a DOX-inducible lentiviral vectorVirus Genes 2013; 46(3): 393 doi: 10.1007/s11262-013-0886-2
14
S. Ezzikouri, B. Kitab, K. Rebbani, A. Marchio, S. Wain‐Hobson, A. Dejean, J.‐P. Vartanian, P. Pineau, S. Benjelloun. Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan populationJournal of Viral Hepatitis 2013; 20(10): 678 doi: 10.1111/jvh.12042
15
E. M. Janahi, M. J. McGarvey. The inhibition of hepatitis B virus by APOBEC cytidine deaminasesJournal of Viral Hepatitis 2013; 20(12): 821 doi: 10.1111/jvh.12192
16
Jian Qiu, Bo Qin, Simon Rayner, Chun-chen Wu, Rong-juan Pei, Song Xu, Yun Wang, Xin-wen Chen. Novel evidence suggests Hepatitis B virus surface proteins participate in regulation of HBV genome replicationVirologica Sinica 2011; 26(2): 131 doi: 10.1007/s12250-011-3190-0
17
Yan-Chang Lei, Yong-Jun Tian, Hong-Hui Ding, Bao-Ju Wang, Yan Yang, You-Hua Hao, Xi-Ping Zhao, Meng-Ji Lu, Fei-Li Gong, Dong-Liang Yang. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replicationWorld Journal of Gastroenterology 2006; 12(46): 7488-7496 doi: 10.3748/wjg.v12.i46.7488
18
Jin Hu, Huiqiang Wang, Lu Yang, Shuo Wu, Yanping Li, Yuhuan Li, Zhuorong Li. Compound IMB-Z inhibits hepatitis B virus replication through increasing APOBEC3G expression and incorporation into viral nucleocapsidsJournal of Global Antimicrobial Resistance 2022; 31: 371 doi: 10.1016/j.jgar.2022.11.006
19
Yong He, Jiahui Zhou, Huizhan Gao, Chuanfeng Liu, Peng Zhan, Xinyong Liu. Broad-spectrum antiviral strategy: Host-targeting antivirals against emerging and re-emerging virusesEuropean Journal of Medicinal Chemistry 2024; 265: 116069 doi: 10.1016/j.ejmech.2023.116069
20
Rebecca K. Holmes, Michael H. Malim, Kate N. Bishop. APOBEC-mediated viral restriction: not simply editing?Trends in Biochemical Sciences 2007; 32(3): 118 doi: 10.1016/j.tibs.2007.01.004
21
Xiaoxia Bai, Ting Tian, Peng Wang, Xiaofu Yang, Zhengping Wang, Minyue Dong. Potential roles of placental human beta‐defensin‐3 and apolipoprotein B mRNA‐editing enzyme catalytic polypeptide 3G in prevention of intrauterine transmission of hepatitis B virusJournal of Medical Virology 2015; 87(3): 375 doi: 10.1002/jmv.24072
22
Bo Qin, Bettina Budeus, Liang Cao, Chunchen Wu, Yun Wang, Xiaoyong Zhang, Simon Rayner, Daniel Hoffmann, Mengji Lu, Xinwen Chen. The amino acid substitutions rtP177G and rtF249A in the reverse transcriptase domain of hepatitis B virus polymerase reduce the susceptibility to tenofovirAntiviral Research 2013; 97(2): 93 doi: 10.1016/j.antiviral.2012.12.007
23
C. Xia, M. Lu, Z. Zhang, Z. Meng, Z. Zhang, C. Shi. TLRs antiviral effect on hepatitis B virus in HepG2 cellsJournal of Applied Microbiology 2008; 105(5): 1720 doi: 10.1111/j.1365-2672.2008.03896.x
24
Sahar Asadi-Asadabad, Hamzeh Sarvnaz, Mohammad Mehdi Amiri, Maryam Mobini, Jalal Khoshnoodi, Mohammad Hojjat-Farsangi, Mahmood Jeddi-Tehrani, Forough Golsaz-Shirazi, Fazel Shokri. Influence of Pattern Recognition Receptor Ligands on Induction of Innate Immunity and Control of Hepatitis B Virus InfectionViral Immunology 2021; 34(8): 531 doi: 10.1089/vim.2021.0040
25
Yuanyuan Lin, Xiaoming Cheng, Yuhu Song, Li Zhou, Peiyuan Li, Ying Chang, Leiming Xu, Jinjian Yao, Jusheng Lin. Construction and expression of hepatitis B virus vector encoding TC-tagged core proteinFrontiers of Medicine in China 2009; 3(4): 396 doi: 10.1007/s11684-009-0056-z
26
C. Wu, X. Zhang, Y. Tian, J. Song, D. Yang, M. Roggendorf, M. Lu, X. Chen. Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replicationJournal of General Virology 2010; 91(2): 483 doi: 10.1099/vir.0.012740-0
27
Bo Qin, RongJuan Pei, TingTing He, ZhaoHui Huang, GuoShao Pan, ChunYu Tu, MengJi Lu, XinWen Chen. Polymerase mutations rtN238R, rtT240Y and rtN248H of hepatitis B virus decrease susceptibility to adefovirChinese Science Bulletin 2013; 58(15): 1760 doi: 10.1007/s11434-013-5770-x